A Trial of SHR0302 Tablets and SHR0302 Base Gel in Patients With Non-segmental Vitiligo

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The study is being conducted to evaluate the efficacy, and safety of SHR0302 tablets as single therapy or in combination with SHR0302 Base gel for patients with non-segmental vitiligo.
Epistemonikos ID: b25853da013d2a64c4361ca4e4eacf805b55b7d6
First added on: Nov 27, 2025